Steely Robert Lee, Collins Donald R, Cohen Benjamin E, Bass Kim
Houston, TX 77002, USA.
Aesthetic Plast Surg. 2004 Jan-Feb;28(1):29-32. doi: 10.1007/s00266-004-3015-8. Epub 2004 May 3.
Despite great advances in modern medicine, postoperative nausea and vomiting (PONV) continue to be a significant problem without a definitive cure. This article describes a prospective study conducted with 143 plastic surgery patients at a single institution between 1998 and 2000 to identify preoperative risk factors for PONV that may be specific to plastic surgery patients. In addition, a prophylactic regimen was identified that demonstrated a decrease in the incidence of PONV from the published incidence of 22% to 3%. The regimen includes the use of multiple antiemetic agents including ondansetron (Zofran) promethazine (Phenergan), and metoclopramide (Reglan), with the addition of dexamethasone (Decadron) in selected cases